Cipher Pharma Cash Flow - Quarterly (NASDAQ:CPHR)

Add to My Stocks
$2.99 $0 (0%) CPHR stock closing price Dec 08, 2016 (Closing)

The financial analysis of CPHR requires an investor to check the cash flows for Cipher Pharma. While its important to look at the Cipher Pharma debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as Cipher Pharma revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. Cipher Pharma stock analysis shows negative net income cash flow of $-27.85M till 2016 Q3. This statement is important because profits alone cannot pay employees, or bills. Cash is required. The cash from operating activities for Cipher Pharma is $ 2016 Q3, which saw an increase from previous quarter.

View and download details of Cipher Pharma cash flows for latest & last 40 quarters
show more
Fiscal year is Jan - Dec2016 Q32016 Q22016 Q1
Net Income Cash Flow
-27.85M-6.06M-2.69M
Depreciation Depletion Amortization Cash-Flow21.99M3.18M1.51M
Net Increase (Decrease) in Assets Liabilities1.49M2.01M1.7M
Cash From (used in) Discontinued Operations---
Other Adjustments Net10.89M5.34M-
Net Cash from (used by) Operating Activities
6.52M4.47M1.41M
Increase (Decrease) in Prop Plant And Equipment-0.54M-0.49M-0.44M
Acquisition Disposition of Subsidiaires---
Increase (Decrease) in Investments---
Other Cash Inflow (Outflow) from Investment Activities-0.07M-0.07M-
Net Cash from (used by) Investment Activities
-0.62M-0.56M-0.44M
Issuance (Purchase) of Equity Shares---
Issuance (Repayment) of Debt Securities---
Increase (Decrease) in Bank & Other Borrowings-0.02M-0.01M-
Payment of Dividends & Other Cash Distributions---
Other Cash from (used by) Financing Activities-3.12M-2.07M-1.03M
Net Cash from (used by) Financing Activities
-2.53M-1.73M-0.79M
Effect of Exchange Rate Changes on Cash-1.42M1.44M
Net Change in Cash & Cash Equivalents
3.41M3.6M1.62M
Cash & Equivalents at Beginning of Year---
Cash & Equivalents at Year End30.6M30.78M28.8M
All figures in USD. M: Millions of USD, B: Billions of USD.

Click here to view our Taro Pharma financial analysis

Cipher Pharma stock price history provides insight into historical stock price fluctuations, and Cipher Pharma stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • Cipher Pharma has cash of $30.6M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the Cipher Pharma stock price.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a positive value of $6.52M for CPHR.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $-0.62M for CPHR stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Cash flow from financing activities shows the flow of cash between Cipher Pharma and its owners and creditors and was $-2.53M till 2016 Q3. Financing activities allow a company to raise capital, and repay bondholders.

Key Financial Ratios For Cipher Pharma Cash Flow

Quarterly Cash Flow Statements For Cipher Pharmaceuticals Inc Peers

Elite Pharma cash flow, RESTOR ROBOTICS cash flow, KemPharma cash flow, NOVAN INC cash flow, Taro Pharma cash flow